Abeona Therapeutics

On this #RareDiseaseDay, we recognize that living with Recessive Dystrophic Epidermolysis Bullosa (RDEB) is a journey marked with unique challenges. We are stronger together. Abeona Therapeutics remains determined to develop a treatment to address the unmet needs within the RDEB community. #RareDiseaseDay #RecessiveDystrophicEpidermolysisBullosa #RDEB #AbeonaTherapeutics

What are you looking forward to in 2025? We asked the question and here is what you said. #patientsfirst #abeonatherapeutics #geneandcelltherapy

Everyone here at Abeona Therapeutics is wishing you a joyful holiday season filled with warmth, hope and peace. We remain committed in our mission to deliver cell and gene therapies for serious diseases. Thank you to everyone who has joined us in this journey. Your support inspires our continued work. #patientsfirst #abeonatherapeutics #geneandcelltherapy #patientinspiration

We are hiring multiple positions in manufacturing, quality control and other areas as we prepare for potential FDA approval and U.S. launch of pz-cel. For more information and to view all of Abeona’s job openings, visit us at: https://lnkd.in/gWWDsqBN. Be aware of fraudulent postings on job platforms, where impersonators falsely claim to represent reputable companies and offer fake job opportunities. Stay alert and protect yourself from online employment scams. - Verify contacts and information independently to ensure authenticity. - Confirm email addresses match the official domain of the company (e.g., [email protected]). - Never pay fees or provide sensitive personal information during the recruitment process. - Be vigilant with communications from unknown individuals or websites, or from businesses with inconsistent domain names. - Be cautious of correspondence from free email accounts (e.g., Yahoo, Hotmail, Gmail). Reputable companies will not solicit candidates using a non-company email address. - Be wary of communications that do not include information about a specific job opening or that provide vague job descriptions, and/or extend a job offer without an interview.?

?? ?? Today we shine a light on the scientists inside Abeona Therapeutics. They never lose sight of their goal; advancing gene therapy to improve the lives of people living with Epidermolysis Bullosa. #ResearchMatters #patientsfirst #everydayisebawareness #abeonatherapeutics #patientvoices #knowledgeiscontagious #cellandgenetherapy #rdeb #patientinspiration #wefightEB

This Thanksgiving Abeona Therapeutics celebrates the voices of hope, perseverance and family. We recognize that appreciation is a powerful healer. Listen to what some people who are impacted by EB are thankful for this year. #AbeonaTherapeutics #WhatAreYouThankfulFor #PatientVoices #GeneAndCellTherapy #RDEB #PatientInspiration #WeFightEB

Last month, Abeona Therapeutics resubmitted a Biologics License Application (BLA) to the FDA for its investigational RDEB treatment. We are thankful to the people who volunteer for research and clinical trials. Your time and commitment bring us one step closer to helping those in need. #AbeonaTherapeutics #AddressingUnmetNeeds #PatientVoices #GeneandCellTherapy #RDEB #PatientInspiration #WeFightEB

The FDA has accepted Abeona’s BLA resubmission for prademagene zamikeracel (pz-cel) in recessive dystrophic epidermolysis bullosa (RDEB) with a PDUFA target action date of April 29, 2025. Read about our latest progress here: https://bit.ly/40I4ukY. #SevereDEB #RDEB #AbeonaTherapeutics

The FDA has accepted Abeona’s BLA resubmission for prademagene zamikeracel (pz-cel) in recessive dystrophic epidermolysis bullosa (RDEB) with a PDUFA target action date of April 29, 2025. Read about our latest progress here: https://bit.ly/40I4ukY. #SevereDEB #RDEB #AbeonaTherapeutics

Today, Abeona Therapeutics announced the resubmission of our BLA to the FDA for prademagene zamikeracel (pz-cel), our investigational autologous cell-based gene therapy, as a potential new treatment for patients with recessive dystrophic epidermolysis bullosa (RDEB). Read about our latest progress here: https://lnkd.in/esy6_iZU. #SevereDEB #RDEB #AbeonaTherapeutics